We are live on ! Find out more
BCM

Bluefin Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 18.42%
This Fund
S&P 500
This Quarter Est. Return
-1.42%
1 Year Est. Return
+18.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.18B
AUM Growth
+$661M
Cap. Flow
+$2.03B
Cap. Flow %
171.04%
Top 10 Hldgs %
88.05%
Holding
249
New
80
Increased
41
Reduced
35
Closed
56

Sector Composition

Rank Sector Weight
1 Technology 29.17%
2 Consumer Discretionary 1.56%
3 Energy 1.06%
4 Consumer Staples 0.95%
5 Healthcare 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPB icon
226
CALL
Spectrum Brands
SPB
$2.07B
-61,300
Closed -$131K
SPB icon
227
PUT
Spectrum Brands
SPB
$2.07B
-25,000
Closed -$3.13K
TECK icon
228
CALL
Teck Resources
TECK
$32.6B
-245,300
Closed -$22.1K
TECK icon
229
Teck Resources
TECK
$32.6B
-87,971
Closed -$3.7M
TECK icon
230
PUT
Teck Resources
TECK
$32.6B
-501,500
Closed -$697K
XLE icon
231
CALL
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
-50,200
Closed -$377
XLE icon
232
PUT
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
-20,000
Closed -$193K
CTLT
233
PUT
DELISTED
CATALENT, INC.
CTLT
-37,500
Closed -$2.81K
SP
234
CALL
DELISTED
SP Plus Corporation
SP
-20,100
Closed -$45.2K
GPP
235
DELISTED
Green Plains Partners LP
GPP
-15,000
Closed -$194K
TYGOW
236
DELISTED
Tigo Energy, Inc. Warrant
TYGOW
-10,695
Closed -$19.6K
TDW.WS.A
237
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
-32,400
Closed -$37.6K
ISEE
238
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-94,904
Closed -$3.73M
HZNP
239
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-1,554,400
Closed -$423K
HZNP
240
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-5,897,500
Closed -$7.85M
IIVI
241
DELISTED
Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock
IIVI
-196,531
Closed -$44.6M

Similar funds

Bluefin Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Bluefin Capital Management held 249 positions worth $1.18B, up 126% from $524M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Bluefin Capital Management deployed $2.03B of net new capital in Q3 2023, opening 80 new positions and adding to 41 existing holdings. Its largest new stake was Microsoft: 944,500 shares worth $298M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $5.86M trimmed.

  • Bluefin Capital Management's largest Q3 2023 buy was Microsoft: 944,500 shares worth $298M.
  • Bluefin Capital Management added most to iShares MSCI Emerging Markets ETF in Q3 2023, an estimated $384M increase.
  • Bluefin Capital Management's biggest Q3 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $5.86M.
  • Bluefin Capital Management fully exited Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock in Q3 2023, selling an estimated $44.6M.
  • Bluefin Capital Management's ten largest holdings make up 88% of its $1.18B portfolio in Q3 2023.
  • Bluefin Capital Management opened 80 new positions and closed 56 in Q3 2023.
  • Bluefin Capital Management's portfolio value rose 126% quarter-over-quarter to $1.18B.

Based on Bluefin Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.